A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome

OBJECTIVE: CHF5633 (Chiesi Farmaceutici S.p.A., Parma, Italy) is the first fully synthetic surfactant enriched by peptide analogues of two human surfactant proteins. We planned to assess safety and tolerability of CHF5633 and explore preliminary efficacy. DESIGN: Multicentre cohort study. PATIENTS:...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arch Dis Child Fetal Neonatal Ed
Main Authors: Sweet, David G, Turner, Mark A, Straňák, Zbyněk, Plavka, Richard, Clarke, Paul, Stenson, Ben J, Singer, Dominique, Goelz, Rangmar, Fabbri, Laura, Varoli, Guido, Piccinno, Annalisa, Santoro, Debora, Speer, Christian P
Format: Artigo
Jezik:Inglês
Izdano: Archives of Disease in Childhood 2017
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739829/
https://ncbi.nlm.nih.gov/pubmed/28465315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2017-312722
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki